CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,194,016 | +1489.1% | 543,200 | +1086.6% | 0.00% | – |
| Q2 2021 | $201,000 | +4925.0% | 45,777 | +5241.5% | 0.00% | – |
| Q1 2021 | $4,000 | -93.0% | 857 | -81.4% | 0.00% | – |
| Q4 2020 | $57,000 | +280.0% | 4,596 | +246.9% | 0.00% | – |
| Q3 2020 | $15,000 | -34.8% | 1,325 | -42.2% | 0.00% | – |
| Q2 2020 | $23,000 | -8.0% | 2,292 | -15.0% | 0.00% | – |
| Q4 2019 | $25,000 | +127.3% | 2,697 | +42.7% | 0.00% | – |
| Q3 2019 | $11,000 | -50.0% | 1,890 | +3.6% | 0.00% | – |
| Q2 2019 | $22,000 | +57.1% | 1,824 | +66.6% | 0.00% | – |
| Q4 2018 | $14,000 | 0.0% | 1,095 | +16.5% | 0.00% | – |
| Q3 2018 | $14,000 | -70.8% | 940 | -66.9% | 0.00% | – |
| Q2 2018 | $48,000 | +166.7% | 2,844 | +258.6% | 0.00% | – |
| Q1 2018 | $18,000 | -14.3% | 793 | 0.0% | 0.00% | – |
| Q4 2017 | $21,000 | +75.0% | 793 | 0.0% | 0.00% | – |
| Q3 2017 | $12,000 | -94.5% | 793 | -96.7% | 0.00% | – |
| Q4 2016 | $217,000 | +1105.6% | 23,973 | +1383.5% | 0.00% | – |
| Q2 2016 | $18,000 | -96.0% | 1,616 | -93.3% | 0.00% | -100.0% |
| Q3 2015 | $450,000 | +22400.0% | 23,973 | +14883.1% | 0.00% | – |
| Q2 2014 | $2,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,050,124 | $10,312,000 | 3.31% |
| Alambic Investment Management, L.P. | 19,934 | $196,000 | 2.15% |
| INGALLS & SNYDER LLC | 1,363,603 | $13,391,000 | 0.92% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,946,000 | 0.80% |
| RA Capital Management | 1,858,474 | $18,250,000 | 0.33% |
| Perceptive Advisors | 2,150,641 | $21,119,000 | 0.31% |
| SPHERA FUNDS MANAGEMENT LTD. | 310,000 | $3,044,000 | 0.30% |
| Eversept Partners, LP | 103,829 | $1,019,601 | 0.23% |
| Opaleye Management Inc. | 100,000 | $982,000 | 0.19% |
| GSA CAPITAL PARTNERS LLP | 58,095 | $570,000 | 0.10% |